Quinupristin/dalfopristin will boost the amount or effect of diazepam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Efficacy and security of parenteral diazepam has not been established in neonate (30 days or much less of age); extended central nervous method depression has been noticed in neonates, seemingly as a consequence https://grahaml799hid4.tokka-blog.com/profile